In vitro activated CD4+ T cells from interferon-gamma (IFN-γ)- deficient mice induce intestinal inflammation in immunodeficient hosts

Clinical and Experimental Immunology

Volumn 118, Issue 2, 1999, Pages 228-234

  Bregenholt, Søren ^a,b   Brimnes, J ^a   Nissen, M H ^a   Claesson, M H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

CD4+ T cells; Inflammatory bowel disease; Interferon gamma; Mucosal immunity; Scid mice

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL PROLIFERATION; COMBINED IMMUNODEFICIENCY; CYTOKINE PRODUCTION; ENTERITIS; HELPER CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, MUCOSAL; IMMUNOCOMPROMISED HOST; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID;

EID: 0032707491     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01058.x     Document Type: Article

References (45)

1. 1 MacDermott RP. The role of the mucosal immune system in inflammatory bowel disease. In: Kagnoff MF, Kiyono H, eds. Essentials of mucosal immunology. San Diego: Academic Press, 1996:321-39.
2. 2 Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-9.
3. 3 Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75:253-61.
4. 4 Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
5. 5 Kulkami AB, Huh CG, Becker D et al. Transforming growth factor beta I null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 1993; 90:770-4.
6. 6 Watanabe M, Ueno Y, Yajima T et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med 1998; 187:389-402.
7. 7 Bregenholt S, Claesson MH. Increased intracellular Th1 cytokines in scid mice with inflammatory bowel disease. Eur J Immunol 1998; 28:379-89.
8. + T-cells reactive to enteric bacterial antigens in spontaneous colitic C3H/HeJBir mice: increased T helper cell type I response and ability to transfer disease. J Exp Med 1998; 187:855-64.
9. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 1996; 184:241-51.
10. + T cells in an experimental model of colitis. Eur J Immunol 1997; 27:17-25.
11. + T cell and proinflammatory Th1-type cytokines. J Immunol 1997; 158:1068-77.
12. 12 Bregenholt S, Delbro D, Claesson MH. T cell transfer and TCR/ cytokine gene deletion models in the study of inflammatory bowel disease. APMIS 1997; 105:655-62.
13. + lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70.
14. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994; 179:589-600.
15. 15 Neurath MF, Fuss I, Kelsall BL, Stüber F, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995; 182:1281-90.
16. + TH1-like responses. J Clin Invest 1996; 98:1010-20.
17. + T-cell subset inhibits antigen specific T-cell responses and prevents colitis. Nature 1997; 389:737-42.
18. 18 Davidson N, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick D. IL-12, but not IFN-γ plays a major role in sustaining the chronic phase of colitis in IL-10 deficient mice. J Immunol 1998; 161:3143-9.
19. 19 van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgal GN, Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109:129-35.
20. 20 Targan SR, Hanauer SB, van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Eng J Med 1997; 337:1029-35.
21. 21 Nielsen OH, Vainer B, Bregenholt S, Claesson MH, Bishop PD, Kirman I. Inflammatory bowel disease: potential therapeutic strategies. Cytokines Cell Mol Ther 1997; 3:267-81.
22. 22 Reimann J, Rudolphi A, Claesson MH. Selective reconstitution of T lymphocyte subsets in scid mice. Immunol Rev 1991; 124:75-95.
23. + T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol 1996; 104:491-500.
24. + αβ T cells in SCID mice with colitis. Eur J Immunol 1996; 26:3074-83.
25. + αβ cells in the colonic lamina propria of scid mice with colitis. Eur J Immunol 1996; 26:1156-63.
26. 26 Bregenholt S, Claesson MH. Splenic T helper cell type I cytokine profile and extramedullar hematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD). Clin Exp Immunol 1998; 111:166-73.
27. + T cells repopulating scid mice with colitis. Eur J Immunol 1998; 28:1785-97.
28. + T-cells from SCID mice with inflammatory bowel disease. Eur J Immunol 1998; 28:3655-63.
29. 29 Bregenholt S, Brimnes J, Reimann J, Claesson MH. Accumulation of immunoglobulin-containing cells in the gut mucosa and presence of faecal immunoglobulin in the severe combined immunodeficient (scid) mice with T cell-induced inflammatory bowel disease (IBD). Clin Exp Immunol 1998; 114:19-25.
30. 30 Bregenholt S, Röpke M, Skov S, Claesson MH. Ligation of MHC class I molecules on peripheral blood T lymphocytes induces new phenotypes and functions. J Immunol 1996; 157:993-9.
31. 31 Nissen MH, Bregenholt S, Nording JA, Claesson MH. CI-esterase inhibitor blocks T lymphocyte proliferation and cytotoxic lymphocyte generation in vitro. Int Immunol 1998; 10:167-73.
32. 32 Skov S, Bregenholt S, Claesson MH. MHC class I ligation of T-cells activates the ZAP70 kinase, leads to an alternative phosphorylation of the TCR/CD3 ζ-chain and induces apoptosis. J Immunol 1997; 158:3189-98.
33. 33 Simpson SJ, Shah S, de Comiskey MJY, Wang B, Mizoguchi E, Bhan AK, Terhorst C. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med 1998; 187:1225-34.
34. high CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease. J Autoimmun 1997; 10:455-9.
35. 35 Hsieh CS, Macatonia SE, O'Garra A, Murphy KM. T cell genetic background determines default T helper phenotype development in vitro. J Exp Med 1995; 181:713-21.
36. + T-cells in immunodeficient adoptive hosts depends on their state of activation, IL-12 responsiveness and CD45RB surface phenotype. J Immunol 1999; 162:3702-10.
37. 37 Rudolphi A, Claesson MH, Reimann J. CD3+ T cells in severe combined immunodeficiency (scid) mice. VI. Rescue of scid-derived, IgM-proilucing B cells by transfer of CD4+ CD8- T cells from various lymphoid organs. Immunology 1992; 77:157-64.
38. 38 Neurath M, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde KH, Strober W, Kollias G. Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 1997; 27:1743-50.
39. 39 Plevy SE, Landers CJ, Prehn J, Carramanzana NM, Deem RL, Shealy D, Targan SR. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol 1997; 159:6276-82.
40. 40 Mosmann TR, Sad S. The expanding universe of T-cell subsets Th1, Th2 and more. Immunol Today 1996; 17:138-46.
41. high subset of CD4+ T cells. Am J Pathol 1996; 148:1503-15.
42. 42 Munder M, Mallo M, Eichmann K, Modolell M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 1998; 187:2103-8.
43. 43 Ulloa L, Doody J, Massagué J. Inhibition of transforming growth factor-β/SMAD signalling by the interteron-γ/STAT pathway. Nature 1999; 397:710-3.
44. 44 Liu LM, Weiner HL. T-cell responses to orally administered antigens and its role in the treatment of autoimmune disease. In: MacDonald TT. ed. Mucosal T cell. Basel: Karger, 1998:139-60.
45. + cells. J Exp Med 1996; 183:2669-74.